雜志介紹

Cell Biology International雜志介紹

《Cell Biology International》是一本以English為主的未開放獲取國際優秀期刊，中文名稱國際細胞生物學，本刊主要出版、報道生物學-CELL BIOLOGY領域的研究動態以及在該領域取得的各方面的經驗和科研成果，介紹該領域有關本專業的最新進展，探討行業發展的思路和方法，以促進學術信息交流，提高行業發展。該刊已被國際權威數據庫SCIE收錄，為該領域相關學科的發展起到了良好的推動作用，也得到了本專業人員的廣泛認可。該刊最新影響因子為3.3，最新CiteScore 指數為7.6。

本刊近期中國學者發表的論文主要有：

• PLAU contributes to the development of cholangiocarcinoma via activating NF-kappa B signaling pathway

  Author: Hu, Mei-Di; Jia, Ling-Hua; Wang, Ming-long

• Tiny Drosophila intestinal stem cells, big power

  Author: Zhai, Jingbo; Li, Wanyang; Liu, Xin; Wang, Di; Zhang, Dongli; Liu, Yanli; Liang, Xiuwen; Chen, Zeliang

• Diagnostic ultrasound-mediated microbubble cavitation dose-dependently improves diabetic cardiomyopathy through angiogenesis

  Author: Zhou, Nan-Qian; Song, Yu-Ting; Liu, Wei-Zhen; Yue, Rui-Zhu; Tian, Xin-Qiao; Yang, Shi-Chang; Yin, Ya-Ling; Li, Peng

• HELQ suppresses migration and proliferation of non-small cell lung cancer cells by repairing DNA damage and inducing necrosis

  Author: Zhong, Nan Shan; Tong, Wei Lai; Zhang, Yu; Xiao, Shi Ning; Liu, Jia Ming; Li, An An; Yao, Ge Liang; Lin, Qing; Liu, Zhi Li

英文介紹

Cell Biology International雜志英文介紹

Each month, the journal publishes easy-to-assimilate, up-to-the minute reports of experimental findings by researchers using a wide range of the latest techniques. Promoting the aims of cell biologists worldwide, papers reporting on structure and function - especially where they relate to the physiology of the whole cell - are strongly encouraged. Molecular biology is welcome, as long as articles report findings that are seen in the wider context of cell biology. In covering all areas of the cell, the journal is both appealing and accessible to a broad audience. Authors whose papers do not appeal to cell biologists in general because their topic is too specialized (e.g. infectious microbes, protozoology) are recommended to send them to more relevant journals. Papers reporting whole animal studies or work more suited to a medical journal, e.g. histopathological studies or clinical immunology, are unlikely to be accepted, unless they are fully focused on some important cellular aspect.

These last remarks extend particularly to papers on cancer. Unless firmly based on some deeper cellular or molecular biological principle, papers that are highly specialized in this field, with limited appeal to cell biologists at large, should be directed towards journals devoted to cancer, there being very many from which to choose.